NAALADase inhibitors useful as pharmaceutical compounds and compositions
US6458775B1 · kind B1 · utility
14Cited by
77References
55Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 2, 1999 |
| Grant date | Oct 1, 2002 |
| Priority date | — |
| Expiry date | Jul 2, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D213/55
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to N-Acetylated &agr;-Linked Acidic Dipeptidase (NAALADase) inhibitors enzyme activity, pharmaceutical compositions comprising such inhibitors, and methods of their use to inhibit NAALADase enzyme activity, thereby effecting neuronal activities, inhibiting angiogenesis, and treating glutamate abnormalities, compulsive disorders, prostate diseases, pain and diabetic neuropathy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.